AAAAAA

   
Results: 1-13 |
Results: 13

Authors: AHSAN N KORSUNSKY Z BEYER KH VESELL ES
Citation: N. Ahsan et al., PYRAZINOYLGUANIDINE IN END-STAGE RENAL-DISEASE - A PROSPECTIVE, PLACEBO-CONTROLLED PILOT-STUDY, Pharmacology, 57(2), 1998, pp. 96-103

Authors: FOLLANSBEE MH BEYER KH GRIFFITH JW VESELL ES
Citation: Mh. Follansbee et al., STUDIES ON PYRAZINOYLGUANIDINE .5. TEMPORAL EFFECTS OVER 24 WEEKS DEMONSTRATING ATTENUATION OF DIABETIC NEPHROPATHY IN STZ-DIABETIC RATS, Pharmacology, 54(5), 1997, pp. 241-255

Authors: FOLLANSBEE MH BEYER KH VESELL ES
Citation: Mh. Follansbee et al., STUDIES ON PYRAZINOYLGUANIDINE .6. PREVENTION OF CATARACTS IN STZ-DIABETIC RATS, Pharmacology, 54(5), 1997, pp. 256-260

Authors: ARAHIM YI BEYER KH VESELL ES
Citation: Yi. Arahim et al., STUDIES ON PYRAZINOYLGUANIDINE .3. DOWN-REGULATION OF LIPOLYSIS IN ISOLATED ADIPOCYTES, Pharmacology, 53(4), 1996, pp. 197-210

Authors: ARAHIM YI RANNELS SL KIMBALL SR BEYER KH VESELL ES
Citation: Yi. Arahim et al., STUDIES ON PYRAZINOYLGUANIDINE .4. UP-REGULATION OF PHOSPHODIESTERASEACTIVITY IN RAT ADIPOSE-TISSUE AND DOWN-REGULATION OF GLUCONEOGENESISAND ADENOSINE-3',5'-MONOPHOSPHATE CONCENTRATIONS IN PERFUSED-RAT-LIVER, Pharmacology, 53(4), 1996, pp. 211-218

Authors: ARAHIM YI BEYER KH VESELL ES
Citation: Yi. Arahim et al., STUDIES ON PYRAZINOYLGUANIDINE .1. CHARACTERIZATION OF METABOLIC EFFECTS IN DIABETIC RATS, Pharmacology, 52(3), 1996, pp. 135-144

Authors: ARAHIM YI BEYER KH VESELL ES
Citation: Yi. Arahim et al., STUDIES ON PYRAZINOYLGUANIDINE .2. COMPARATIVE DRUG AND DOSE EFFECTS ON GLUCOSE AND LIPID-METABOLISM IN STREPTOZOTOCIN-INDUCED DIABETIC RATS, Pharmacology, 52(3), 1996, pp. 145-152

Authors: AHSAN N MANNING EC CHEUNG JY KORSUNSKY JY VESELL ES BEYER KH
Citation: N. Ahsan et al., PYRAZINOYLGUANIDINE (PZG) LOWERS SERUM TRIGLYCERIDES AND RAISES HDL-CIN END-STAGE RENAL-DISEASE (ESRD) PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 571-571

Authors: VESELL ES CHAMBERS CE SEATON TDA PASSANANTI GT DEMERS LM BEYER KH
Citation: Es. Vesell et al., PYRAZINOYLGUANIDINE DOWN-REGULATES THE GLUCOSE FATTY-ACID CYCLE IN HYPERTENSIVE, HYPERINSULINEMIC DIABETIC-PATIENTS, Journal of clinical pharmacology, 34(12), 1994, pp. 1234-1245

Authors: BEYER KH
Citation: Kh. Beyer, CHLOROTHIAZIDE - HOW THE THIAZIDES EVOLVED AS ANTIHYPERTENSIVE THERAPY, Hypertension, 22(3), 1993, pp. 388-391

Authors: VESELL ES CHAMBERS CE PASSANANTI GT DEMERS LM BEYER KH
Citation: Es. Vesell et al., EFFECTS OF PYRAZINOYLGUANIDINE ON THE GLUCOSE FATTY-ACID CYCLE IN NORMAL SUBJECTS AND PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of clinical pharmacology, 33(9), 1993, pp. 823-831

Authors: BEYER KH WARD TD VARY JE GELARDEN RT KNUTSON DW VESELL ES
Citation: Kh. Beyer et al., CONTRASTING EFFECTS OF PYRAZINOYLGUANIDINE AND HYDROCHLOROTHIAZIDE INPATIENTS WITH RENAL-INSUFFICIENCY, Journal of clinical pharmacology, 33(6), 1993, pp. 554-561

Authors: BEYER KH DROSTE A
Citation: Kh. Beyer et A. Droste, IMMUNOLOGICAL INVESTIGATIONS ON BARBITURA TES - THE EFFECT OF STRUCTURE CHARACTERISTICS ON THE CROSS-REACTIVITY, Die Pharmazie, 48(5), 1993, pp. 387-389
Risultati: 1-13 |